Hengrui Medicine Says Q3 Net Profit Rose 88.92% Year Over Year
Story updates
08:57:15 AM UTC
SquawkNews
中國恆瑞醫藥三季度淨利同比增近九成，惟前三季創新藥銷售收入增速遜預期 路透北京10月27日 - 中國龍頭藥企--恆瑞醫藥600276.SS1276.HK周二公布，三季度淨利同比增近九成，因對外許可收入
Related stories
Salesforce Signs Agreement to Acquire Rune Technologies
Salesforce has signed an agreement to acquire Rune Technologies.
M impact | EQUITY | Oct 29, 2026, 09:06 PM UTC
Salesforce agrees to acquire Rune Technologies
Salesforce signed a definitive agreement to acquire Rune Technologies.
M impact | EQUITY | Oct 29, 2026, 09:06 PM UTC
FedEx Freight Forecasts Holiday-Quarter Earnings Above Estimates
FedEx Freight cited improving volumes and pricing. It also reported quarterly profit and revenue above expectations, and shares rose 2.1% in extended trading.
M impact | EQUITY | Oct 29, 2026, 09:05 PM UTC
Southern Missouri Bancorp CFO to Resign; Matthew Funke Named Principal Financial Officer
Stefan Chkautovich will resign effective November 7, 2026. President and Chief Administrative Officer Matthew T. Funke will become the company’s principal financial officer.
M impact | EQUITY | Oct 29, 2026, 09:05 PM UTC
First Solar Q3 Earnings Rise, Revenue Falls
M impact | EQUITY | Oct 29, 2026, 09:04 PM UTC
International Holding Company PJSC Shares Hit 4-year Low
International Holding Company PJSC shares decreased to 340.00 AED, the lowest since September 2022. Over the past 4 weeks, International Holding Company PJSC lost 6.52%, and in the
L impact | EQUITY | Oct 29, 2026, 09:03 PM UTC